DE69920362D1 - Neue Makrolidderivate - Google Patents

Neue Makrolidderivate

Info

Publication number
DE69920362D1
DE69920362D1 DE69920362T DE69920362T DE69920362D1 DE 69920362 D1 DE69920362 D1 DE 69920362D1 DE 69920362 T DE69920362 T DE 69920362T DE 69920362 T DE69920362 T DE 69920362T DE 69920362 D1 DE69920362 D1 DE 69920362D1
Authority
DE
Germany
Prior art keywords
compounds
formula
macrolide derivatives
new macrolide
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69920362T
Other languages
English (en)
Other versions
DE69920362T2 (de
Inventor
Brian Scott Bronk
Hengmiao Cheng
Jason Kenneth Dutra
Michael Anthony Letavic
Robert John Rafka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE69920362D1 publication Critical patent/DE69920362D1/de
Publication of DE69920362T2 publication Critical patent/DE69920362T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69920362T 1998-10-09 1999-10-08 Neue Makrolidderivate Expired - Fee Related DE69920362T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10383898P 1998-10-09 1998-10-09
US103838P 1998-10-09

Publications (2)

Publication Number Publication Date
DE69920362D1 true DE69920362D1 (de) 2004-10-28
DE69920362T2 DE69920362T2 (de) 2006-02-09

Family

ID=22297279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920362T Expired - Fee Related DE69920362T2 (de) 1998-10-09 1999-10-08 Neue Makrolidderivate

Country Status (10)

Country Link
US (1) US6100240A (de)
EP (1) EP0992509B1 (de)
JP (1) JP3679656B2 (de)
AT (1) ATE277062T1 (de)
BR (1) BR9905089A (de)
CA (1) CA2286511C (de)
DE (1) DE69920362T2 (de)
DK (1) DK0992509T3 (de)
ES (1) ES2226294T3 (de)
PT (1) PT992509E (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (de) * 1997-09-10 2010-01-27 Merial Ltd. 9a-Azalide als antimikrobielle Wirkstoffe für die Veterinärmedizin
DK1011689T3 (da) * 1997-09-10 2007-05-21 Merial Ltd Anvendelse af 9a-azalider som veterinære antimikrobielle midler
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
CA2359708C (en) * 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
CA2292359C (en) * 1999-01-28 2004-09-28 Pfizer Products Inc. Novel azalides and methods of making same
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
EA200100983A1 (ru) * 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
CA2407448A1 (en) * 2000-04-27 2001-11-01 Pfizer Products Inc. The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
JP2005538927A (ja) * 2002-01-17 2005-12-22 コーザン バイオサイエンシス インコーポレイテッド アミドマクロライド
AU2003211113B2 (en) 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
AU2003219770B2 (en) 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2003070173A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CN101423539B (zh) * 2008-12-09 2011-04-27 山东大学 4″,11-二氨基甲酸酯阿奇霉素衍生物、制备方法及其药物组合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5641753A (en) * 1996-03-25 1997-06-24 Chris E. Platt 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined with sulfisoxazole
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
CA2286511A1 (en) 2000-04-09
US6100240A (en) 2000-08-08
BR9905089A (pt) 2000-08-08
JP2000119294A (ja) 2000-04-25
EP0992509A3 (de) 2001-03-07
EP0992509A2 (de) 2000-04-12
ES2226294T3 (es) 2005-03-16
DK0992509T3 (da) 2004-12-20
DE69920362T2 (de) 2006-02-09
JP3679656B2 (ja) 2005-08-03
ATE277062T1 (de) 2004-10-15
CA2286511C (en) 2003-07-08
EP0992509B1 (de) 2004-09-22
PT992509E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
DE69920362D1 (de) Neue Makrolidderivate
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
AU2134402A (en) Antiviral agents
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
EA199901014A1 (ru) C-4"-замещенные макролидные производные
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
MA27040A1 (fr) Nucleosides substitues en 4'
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
TR200103395T2 (tr) 13-metil eritromisin türevleri.
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
FI944823A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
AP9801377A0 (en) Tricyclic erythromycin derivatives.
DE69330601D1 (de) Serotoninergische ergolin derivate
AP9801235A0 (en) Erythromycin derivatives.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
ATE234320T1 (de) Beta,beta-disubstituierte derivate von 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee